US regulators will decide in July whether to approve Qnexa, the first obesity drug in more than a decade, extending the initial deadline by three months, the California-based drug-maker VIVUS said. The extra time is a “standard extension period” offered by the US Food and Drug Administration in order to review additional risk management strategies [...]
Archives: 11 April 2012
April 11, 2012
April 11, 2012
Antioxidant may disrupt Alzheimer’s disease process
ScienceDaily (Apr. 10, 2012) Alzheimer’s disease (AD) is now the sixth leading cause of death among Americans, affecting nearly 1 in 8 people over the age of 65. There is currently no treatment that alters the course of this disease. However, an increasing amount of evidence suggests that changes in the way the body [...]
April 11, 2012
Dieters Share Success Strategies
TUESDAY, April 10 (HealthDay News) — Many obese Americans who try to lose weight are successful, at least short-term, using traditional methods, according to a new study. Researchers who evaluated the strategies of more than 1,500 successful obese dieters found that eating less fat, exercising more, taking prescription diet pills and joining a commercial weight-loss [...]
Welcome